Active-ingredient Dossier
Zoledronic Acid Monohydrate
Active-ingredient Dossier for Zoledronic Acid Monohydrate (bisphosphonate). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: DEZTRON
- Brand: OSTEOVAN
- Brand: ACLASTA
- Brand: ZOLEDRONATE-DRLA
- Brand: ZOLEDRONATE-RDY
- Brand: ACLONAT
- Therapeutic area: Musculoskeletal
- Therapeutic area: Oncology
What is
Zoledronic Acid Monohydrate Zoledronic Acid Monohydrate is a bisphosphonate.
Australian brands containing
Zoledronic Acid Monohydrate — APO-Zoledronic — DEZTRON — OSTEOVAN — ACLASTA — ZOLEDRONATE-DRLA — ZOLEDRONATE-RDY — Zoledronic — ACLONAT — APOTEX-Zoledronic — BONEZOL — PAGLED — SKELEZOL
Therapeutic areas
Zoledronic Acid Monohydrate is registered in oncology (10 brands) and endocrinology (7 brands).
Sponsor landscape
Zoledronic Acid Monohydrate is marketed by Dr Reddys Laboratories, Arrotex Pharmaceuticals, Sandoz, Medsurge Pharma, Accord Healthcare, and Fresenius Kabi.
PBS and regulatory activity
Two brands containing Zoledronic Acid Monohydrate have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 November 2009, and the latest AusPAR was published on 29 July 2011.